Stock listing

NASDAQ:MIRA MIRA Pharmaceuticals, Inc. Stock

Home listing (NASDAQ) of MIRA Pharmaceuticals, Inc.

Follow MIRA Pharmaceuticals, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:MIRA

$0.291 USD -0.077 (-20.9%)

Close on Nov 20, 2026

Past year -78.4% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.255 – $0.392 USDNov 20, 2026
Volume
556,100 sharesNov 20, 2026
Market cap
$12.23M USDAt the close on Nov 20, 2026 · price × 42.02M shares outstanding
52-week range
$0.255 – $1.690 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$489,843 USDMedian day 102,850 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
MIRA Pharmaceuticals, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:MIRA · Home$0.291 USD-0.077 (-20.9%)556,100$0.392$0.392$0.255$0.368Close on Nov 20, 2026
Frankfurt:K6S€0.527 EUR-0.047 (-8.3%)—€0.526€0.527€0.526€0.574Close on Nov 19, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:MIRA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.291-0.077-20.9%$0.392$0.392$0.255556,100
$0.368-0.223-37.7%$0.590$0.590$0.331589,600
$0.591-0.049-7.7%$0.645$0.645$0.580160,200
$0.640+0.009+1.4%$0.640$0.661$0.620164,100
$0.631-0.029-4.4%$0.640$0.665$0.61158,300
$0.660+0.012+1.9%$0.638$0.664$0.61190,900
$0.648+0.026+4.2%$0.622$0.660$0.61763,200
$0.622+0.001+0.2%$0.620$0.632$0.60352,500
$0.621+0.002+0.3%$0.610$0.640$0.60050,300
$0.619+0.048+8.4%$0.560$0.630$0.550236,900
$0.571+0.031+5.7%$0.540$0.588$0.54028,100
$0.540-0.021-3.7%$0.568$0.575$0.520115,000
$0.561+0.043+8.3%$0.520$0.600$0.52079,700
$0.518-0.019-3.5%$0.530$0.550$0.51083,100
$0.537-0.012-2.2%$0.589$0.589$0.530132,200
$0.549-0.023-4.0%$0.589$0.589$0.510207,900
$0.572+0.016+2.9%$0.574$0.630$0.552378,400
$0.556+0.006+1.1%$0.550$0.578$0.540722,800
$0.550+0.017+3.2%$0.540$0.570$0.53587,900
$0.533-0.087-14.0%$0.647$0.647$0.518252,700
$0.620-0.009-1.4%$0.630$0.660$0.600106,100
$0.629-0.053-7.8%$0.730$0.730$0.622100,200
$0.682+0.032+4.9%$0.665$0.693$0.665128,700
$0.650+0.008+1.2%$0.645$0.661$0.64510,500
$0.642+0.010+1.6%$0.626$0.647$0.62366,100
$0.632-0.026-4.0%$0.680$0.680$0.631123,200
$0.658-0.024-3.5%$0.635$0.679$0.626128,600
$0.682+0.016+2.4%$0.667$0.686$0.66075,900
$0.666-0.039-5.5%$0.699$0.700$0.66067,700
$0.705-0.041-5.5%$0.759$0.759$0.68590,000
$0.746+0.043+6.1%$0.720$0.750$0.70352,400
$0.703-0.007-1.0%$0.710$0.710$0.681142,500
$0.710-0.002-0.3%$0.722$0.741$0.70367,700
$0.712-0.024-3.3%$0.759$0.760$0.700105,700
$0.736+0.006+0.8%$0.730$0.750$0.71186,400
$0.730+0.007+1.0%$0.730$0.758$0.711158,000
$0.723-0.122-14.4%$0.840$0.850$0.620667,700
$0.845-0.027-3.1%$0.859$0.869$0.82072,100
$0.872-0.031-3.4%$0.870$0.900$0.86561,400
$0.903+0.003+0.3%$0.898$0.911$0.87565,800
$0.900+0.060+7.1%$0.860$0.900$0.85094,700
$0.840-0.018-2.1%$0.858$0.860$0.83154,100
$0.858-0.048-5.3%$0.936$0.940$0.850118,600
$0.906+0.027+3.1%$0.865$0.919$0.847127,800
$0.879+0.047+5.6%$0.821$0.900$0.798387,600
$0.832+0.073+9.6%$0.789$0.832$0.770682,600
$0.759+0.039+5.4%$0.730$0.760$0.722131,400
$0.720+0.006+0.8%$0.720$0.737$0.71076,500
$0.714-0.039-5.2%$0.753$0.754$0.71471,500
$0.753-0.021-2.7%$0.766$0.780$0.728171,500
$0.774-0.015-1.9%$0.789$0.820$0.774105,500
$0.789+0.008+1.0%$0.790$0.830$0.759138,400
$0.781+0.005+0.6%$0.771$0.794$0.75653,200
$0.776+0.012+1.6%$0.760$0.810$0.751177,200
$0.764+0.024+3.2%$0.735$0.850$0.735338,500
$0.740-0.110-12.9%$0.830$0.840$0.731490,500
$0.850-0.010-1.2%$0.857$0.935$0.825575,000
$0.860+0.090+11.7%$0.740$1.100$0.72129,281,100
$0.770+0.020+2.7%$0.750$0.782$0.75044,300
$0.750-0.020-2.6%$0.750$0.779$0.75031,800
$0.770+0.020+2.7%$0.750$0.778$0.74044,100
$0.750-0.025-3.2%$0.770$0.774$0.75027,300
$0.775-0.013-1.6%$0.800$0.810$0.76834,700
$0.788+0.024+3.1%$0.779$0.825$0.77065,100
$0.764+0.054+7.6%$0.720$0.820$0.720117,400
$0.710-0.060-7.8%$0.770$0.796$0.71041,700
Ticker
NASDAQ:MIRA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All MIRA Pharmaceuticals, Inc. news

MIRA Pharmaceuticals, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
19 in the last 12 months · 79 in all · newest Nov 17, 2026 · oldest 2023
Decks
3 decks · latest October 2026

Where MIRA Pharmaceuticals, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:MIRA · Home listing · This pageNASDAQUnited StatesUSD
gettex:K6SgettexGermanyEUR
Lang & Schwarz:A3EQWLLang & SchwarzGermanyEUR
LS Exchange:A3EQWLLS ExchangeGermanyEUR
BOATS:MIRABOATSUnited StatesUSD
Tradegate:K6STradegateGermanyEUR
Dusseldorf:K6SDusseldorfGermanyEUR
Frankfurt:K6SFrankfurtGermanyEUR
Hamburg:K6SHamburgGermanyEUR
Munich:K6SMunichGermanyEUR
Stuttgart:K6SStuttgartGermanyEUR

Valuation

Price/book 1.8× against a median of 11.9×: 3rd lowest of 7 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$5.26M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
1.8×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
1.48

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
MIRA Pharmaceuticals, Inc. · NASDAQ:MIRAUS$12.23MUS$5.26Mn/an/an/a1.8×n/a0.0×1.48
Seres Therapeutics, Inc. · NASDAQ:MCRBUS$12.64MUS$30.89Mn/a14.5×n/a0.6×n/a1.7×1.21
Passage Bio, Inc. · NASDAQ:PASGUS$12.61M−US$7.55Mn/an/an/a252×n/a0.0×1.94
Allarity Therapeutics, Inc. · NASDAQ:ALLRUS$12.56MUS$21.48Mn/a61.4×n/an/an/an/a1.40
Lobe Sciences Ltd · CSE:LOBEUS$12.52MUS$8.89Mn/an/an/a9.5×n/a0.0×0.31
Biophytis SA · EURONEXT:ALBPSUS$12.47MUS$19.44Mn/an/an/an/an/an/an/a
Genflow Biosciences PLC · LSE:GENFUS$12.06MUS$11.23Mn/an/an/a48.5×n/a0.0×n/a
BioCardia, Inc. · NASDAQ:BCDAUS$11.88MUS$10.22Mn/an/an/a14.2×n/a0.7×0.42
Xintela AB · OMXSTO:XINTUS$11.88MUS$11.81Mn/a39.8×n/an/an/an/an/a
Pluri Inc. · NASDAQ:PLURUS$11.85MUS$38.65Mn/a26.5×n/an/an/an/a0.53
Synlogic Inc · OTC:SYBXUS$11.76MUS$201,442n/an/an/a1.2×n/a0.0×0.50
Median of the othersUS$12.26MUS$11.52M33.2×11.9×0.0×0.53

Forecasts

1 buy · Analysts' consensus from EODHD, read Nov 21, 2026. Not 6ix's view and not investment advice.

Price target
3.50 USD · Analysts' mean
EPS, year to Dec 2026
-0.12 · 1 analyst

Team and board

Officers

OfficerRole
Erez AminovChairman of the Board and Chief Executive Officer
Andriy MushakChief Financial Officer
Itzchak AngelChief Scientific Advisor

Board

DirectorRole
Erez AminovChairman of the Board and Chief Executive Officer
Denil N. ShekhatDirector
Matthew Del GiudiceDirector
Matthew Pratt WhalenDirector
Ned MacPhersonDirector

Events

Next results
Nov 26, 2026 (expected)
QuarterResultsShare move
Q2 2026Aug 12, 2026−3.6%
Q1 2026Jun 3, 2026+1.9%
Q4 2025Feb 25, 2026+6.4%
Q3 2025Nov 13, 2025 · Before open−6.3%
Q2 2025Aug 14, 2025 · After close+2.0%
Q1 2025May 14, 2025 · After close+6.8%
Q4 2024Feb 26, 20250.0%
Q3 2024Nov 12, 2024 · After close−2.5%
Q2 2024Aug 13, 2024 · After close−5.8%
Q1 2024May 13, 2024 · After close+3.0%
All 13 quarters
QuarterResultsShare move
Q4 2023Feb 28, 2024−4.3%
Q3 2023Nov 13, 2023 · After close+11.7%
Q2 2023Aug 30, 2023−1.7%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (October 2026)Investor deck30 slidesOctober 2026
Investor Presentation (April 2026)Investor deck56 slidesApril 2026
Investor Presentation (June 2025)Investor deck36 slidesJune 2025

Open Decks

IPO

Priced at US$7.00 a share on Aug 2, 2023.

Price
US$7.00 a share
Shares offered
1,275,000 shares of common stock
Offering size
US$8.9 million
Underwriters' option
Up to 191,250 more shares
Listing
MIRA on the Nasdaq Capital Market
Underwriter
Kingswood Investments
Shares delivered
On or about Aug 7, 2023

Steps

StepWhen
Draft sent to the SEC in confidenceJun 29, 2022
Filed publiclyJun 29, 2023
Amended 5 timesNewest Jul 28, 2023
Shares registered with an exchangeJul 31, 2023
Declared effective by the SECAug 2, 2023
Final prospectus, with the priceAug 4, 2023

Open IPO · From the cover of the final prospectus (424B1) filed Aug 4, 2023

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020
Revenue00000
Cost of revenue8.53M
Gross profit-8.53M
Research and development1.72M3.31M1.57M2.35M684.4K14.6K
Selling, general and administrative8.77M4.71M6.50M2.99M770.1K158.9K
Operating income-10.5M-8.02M-8.53M-7.05M-2.15M-67.6K
Depreciation and amortization2732.3K7.05M2.15M202.9K
EBITDA-8.02M-7.79M00135.3K
Interest expense-165.7K3.46M10.3K24.4K364
Income before tax-10.4M-7.85M-12.0M-7.06M-2.18M-68.0K
Income tax-8.53K-7.05K-2.15K-203
Net income-10.4M-7.85M-12.0M-7.06M-2.18M-68.0K
Earnings per share, basic-1.35-0.51-0.85-0.40-0.15-0.00
Earnings per share, diluted-1.35-0.51-0.85-0.40

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents6.35M2.83M4.60M351.0K2.81M3.49K
Short-term investments4.68M0
Receivables11.9K
Inventory-11.9K
Current assets11.1M2.89M4.86M494.4K2.91M3.49K
Property, plant and equipment363.7K
Total assets11.1M2.92M4.93M858.1K3.36M22.4K
Accounts payable129.2K723.3K538.6K905.6K228.4K
Current liabilities702.1K723.3K558.1K1.37M1.09M90.4K
Total debt5.06K491.2K293.1K90.0K
Total liabilities702.1K723.3K558.1K1.45M1.09M90.4K
Shareholders' equity10.4M2.20M4.37M-596.2K2.26M-68.0K
Shares outstanding41.9M16.6M14.8M13.3M14.7M14.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations-4.66M-5.56M-4.53M-5.60M-1.38M-68.0K
Capital spending0-4-100-3
Free cash flow-4.66M-5.56M-4.53M-5.60M-1.38M-68.0K
Cash from financing8.18M3.79M8.78M3.15M4.18M71.1K
Change in cash3.51M-1.77M4.25M-2.46M2.81M3.49K

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 16, 2026Quarterly reportSEC
8-K · Current reportNov 16, 2026Current reportSEC
8-K · Current reportOct 28, 2026Current reportSEC
8-K · Current reportOct 22, 2026Current reportSEC
8-K · Current reportSep 17, 2026Current reportSEC
8-K · Current reportSep 16, 2026Meeting outcomeSEC
8-K · Current reportSep 1, 2026Current reportSEC
10-Q · Quarterly reportAug 12, 2026Quarterly reportSEC
8-K · Current reportAug 6, 2026Current reportSEC
8-K · Current reportJul 31, 2026Current reportSEC
All 200 filings
FilingDateTypeFiled with
DEF 14A · Proxy statementJul 28, 2026Meeting noticeSEC
8-K · Current reportJul 10, 2026Current reportSEC
8-K · Current reportJul 6, 2026Current reportSEC
8-K · Current reportJun 25, 2026Current reportSEC
8-K · Current reportJun 17, 2026Current reportSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
3 · Initial statement of ownershipJun 9, 2026Insider tradeSEC
8-K · Current reportJun 8, 2026Management or board changeSEC
8-K · Current reportJun 4, 2026Material contractSEC
8-K · Current reportMay 27, 2026Material contractSEC
10-Q · Quarterly reportMay 14, 2026Quarterly reportSEC
8-K · Current reportMay 13, 2026Current reportSEC
8-K · Current reportMay 13, 2026Current reportSEC
4 · Change in ownershipApr 1, 2026Insider tradeSEC
10-K · Annual reportMar 31, 2026Annual reportSEC
8-K · Current reportMar 23, 2026Current reportSEC
8-K · Current reportMar 3, 2026Current reportSEC
5 · Annual statement of ownershipFeb 17, 2026Insider tradeSEC
8-K · Current reportFeb 2, 2026Current reportSEC
8-K · Current reportDec 19, 2025Management or board changeSEC
8-K · Current reportDec 5, 2025Current reportSEC
424B5 · ProspectusDec 5, 2025Offer documentSEC
10-Q · Quarterly reportNov 13, 2025Quarterly reportSEC
8-K · Current reportOct 23, 2025Current reportSEC
8-K · Current reportOct 16, 2025Current reportSEC
8-K · Current reportOct 15, 2025Current reportSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
3 · Initial statement of ownershipOct 3, 2025Insider tradeSEC
8-K · Current reportSep 30, 2025Acquisition or disposalSEC
8-K · Current reportSep 22, 2025Current reportSEC
4 · Change in ownershipSep 18, 2025Insider tradeSEC
8-K · Current reportSep 15, 2025Current reportSEC
8-K · Current reportSep 11, 2025Management or board changeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
8-K · Current reportAug 19, 2025Current reportSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
8-K · Current reportAug 12, 2025Current reportSEC
DEFM14AAug 8, 2025Meeting noticeSEC
DEFA14A · Additional proxy materialAug 8, 2025Meeting noticeSEC
PRER14AJul 29, 2025Other filingsSEC
8-K · Current reportJul 29, 2025Current reportSEC
8-K · Current reportJul 28, 2025Current reportSEC
8-K · Current reportJul 10, 2025Current reportSEC
8-K · Current reportJul 8, 2025Current reportSEC
8-K · Current reportJul 2, 2025Current reportSEC
8-K · Current reportJun 30, 2025Current reportSEC
8-K · Current reportJun 24, 2025Current reportSEC
8-K · Current reportJun 17, 2025Current reportSEC
PREM14AJun 17, 2025Other filingsSEC
3 · Initial statement of ownershipJun 10, 2025Insider tradeSEC
8-K · Current reportMay 28, 2025Current reportSEC
8-K · Current reportMay 21, 2025Material contractSEC
10-Q · Quarterly reportMay 14, 2025Quarterly reportSEC
8-K · Current reportMay 8, 2025Current reportSEC
8-K · Current reportMay 6, 2025Current reportSEC
8-K · Current reportApr 23, 2025Current reportSEC
10-K/A · Annual report, amendedApr 17, 2025Annual reportSEC
424B5 · ProspectusApr 16, 2025Offer documentSEC
8-K · Current reportApr 16, 2025Current reportSEC
10-K/A · Annual report, amendedApr 15, 2025Annual reportSEC
8-K · Current reportApr 11, 2025Current reportSEC
8-K · Current reportApr 1, 2025Current reportSEC
10-K · Annual reportMar 28, 2025Annual reportSEC
8-K · Current reportMar 24, 2025Material contractSEC
8-K · Current reportMar 13, 2025Current reportSEC
8-K · Current reportMar 4, 2025Current reportSEC
8-K · Current reportDec 20, 2024Current reportSEC
8-K · Current reportDec 19, 2024Current reportSEC
4 · Change in ownershipDec 10, 2024Insider tradeSEC
4 · Change in ownershipDec 10, 2024Insider tradeSEC
4 · Change in ownershipDec 10, 2024Insider tradeSEC
4 · Change in ownershipDec 10, 2024Insider tradeSEC
4 · Change in ownershipDec 10, 2024Insider tradeSEC
4 · Change in ownershipDec 10, 2024Insider tradeSEC
8-K · Current reportDec 10, 2024Current reportSEC
4 · Change in ownershipNov 27, 2024Insider tradeSEC
3 · Initial statement of ownershipNov 26, 2024Insider tradeSEC
8-K · Current reportNov 21, 2024Management or board changeSEC
144 · Notice of proposed saleNov 19, 2024Other filingsSEC
8-K · Current reportNov 19, 2024Current reportSEC
10-Q · Quarterly reportNov 12, 2024Quarterly reportSEC
8-K · Current reportOct 25, 2024Current reportSEC
8-K · Current reportOct 21, 2024Current reportSEC
424B5 · ProspectusSep 27, 2024Offer documentSEC
S-8 · Registration statement for employee plansSep 27, 2024Offer documentSEC
8-K · Current reportSep 12, 2024Meeting outcomeSEC
8-K · Current reportSep 10, 2024Current reportSEC
144/A · Notice of proposed sale, amendedSep 6, 2024Other filingsSEC
144 · Notice of proposed saleSep 4, 2024Other filingsSEC
4 · Change in ownershipAug 30, 2024Insider tradeSEC
8-K · Current reportAug 23, 2024Current reportSEC
EFFECT · Notice that a registration is effectiveAug 19, 2024Other filingsSEC
10-Q/A · Quarterly report, amendedAug 16, 2024Quarterly reportSEC
CORRESP · Letter to the SECAug 15, 2024Other filingsSEC
UPLOAD · Letter from the SECAug 15, 2024Other filingsSEC
10-Q · Quarterly reportAug 13, 2024Quarterly reportSEC
S-3 · Registration statementAug 12, 2024Offer documentSEC
8-K · Current reportAug 9, 2024Current reportSEC
8-K · Current reportAug 8, 2024Current reportSEC
DEFA14A · Additional proxy materialJul 26, 2024Meeting noticeSEC
DEF 14A · Proxy statementJul 26, 2024Meeting noticeSEC
8-K · Current reportJul 24, 2024Current reportSEC
8-K · Current reportJul 19, 2024Current reportSEC
8-K · Current reportJul 12, 2024Current reportSEC
8-K · Current reportJun 28, 2024Management or board changeSEC
4 · Change in ownershipJun 21, 2024Insider tradeSEC
4 · Change in ownershipMay 30, 2024Insider tradeSEC
8-K · Current reportMay 29, 2024Management or board changeSEC
4 · Change in ownershipMay 22, 2024Insider tradeSEC
10-Q · Quarterly reportMay 13, 2024Quarterly reportSEC
10-K · Annual reportApr 1, 2024Annual reportSEC
4 · Change in ownershipMar 27, 2024Insider tradeSEC
4 · Change in ownershipMar 27, 2024Insider tradeSEC
4 · Change in ownershipMar 27, 2024Insider tradeSEC
4 · Change in ownershipMar 27, 2024Insider tradeSEC
4 · Change in ownershipMar 27, 2024Insider tradeSEC
4 · Change in ownershipMar 27, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 22, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 22, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 22, 2024Insider tradeSEC
8-K · Current reportMar 13, 2024Management or board changeSEC
8-K · Current reportMar 7, 2024Current reportSEC
8-K · Current reportJan 17, 2024Management or board changeSEC
EFFECT · Notice that a registration is effectiveDec 28, 2023Other filingsSEC
4 · Change in ownershipDec 27, 2023Insider tradeSEC
SC 13D/A · Big-stake notice, amendedDec 27, 2023Big-stake noticeSEC
CORRESP · Letter to the SECDec 22, 2023Other filingsSEC
UPLOAD · Letter from the SECDec 22, 2023Other filingsSEC
S-1 · Registration statementDec 18, 2023Offer documentSEC
8-K · Current reportDec 1, 2023Management or board changeSEC
SC 13D/A · Big-stake notice, amendedNov 20, 2023Big-stake noticeSEC
3 · Initial statement of ownershipNov 20, 2023Insider tradeSEC
8-K · Current reportNov 20, 2023Material contractSEC
4 · Change in ownershipNov 17, 2023Insider tradeSEC
424B3 · ProspectusNov 13, 2023Offer documentSEC
10-Q · Quarterly reportNov 13, 2023Quarterly reportSEC
3 · Initial statement of ownershipNov 3, 2023Insider tradeSEC
8-K · Current reportOct 25, 2023Management or board changeSEC
3 · Initial statement of ownershipOct 12, 2023Insider tradeSEC
SC 13D/A · Big-stake notice, amendedOct 12, 2023Big-stake noticeSEC
424B3 · ProspectusSep 18, 2023Offer documentSEC
10-Q · Quarterly reportSep 15, 2023Quarterly reportSEC
8-K · Current reportAug 31, 2023Management or board changeSEC
4 · Change in ownershipAug 24, 2023Insider tradeSEC
4 · Change in ownershipAug 21, 2023Insider tradeSEC
4 · Change in ownershipAug 21, 2023Insider tradeSEC
4 · Change in ownershipAug 21, 2023Insider tradeSEC
4 · Change in ownershipAug 21, 2023Insider tradeSEC
SC 13D · Big-stake noticeAug 14, 2023Big-stake noticeSEC
8-K · Current reportAug 7, 2023Material contractSEC
4 · Change in ownershipAug 4, 2023Insider tradeSEC
424B4 · ProspectusAug 4, 2023Offer documentSEC
424B1 · ProspectusAug 4, 2023Offer documentSEC
EFFECT · Notice that a registration is effectiveAug 3, 2023Other filingsSEC
3 · Initial statement of ownershipAug 2, 2023Insider tradeSEC
3 · Initial statement of ownershipAug 2, 2023Insider tradeSEC
3 · Initial statement of ownershipAug 2, 2023Insider tradeSEC
3 · Initial statement of ownershipAug 2, 2023Insider tradeSEC
3 · Initial statement of ownershipAug 2, 2023Insider tradeSEC
3 · Initial statement of ownershipAug 2, 2023Insider tradeSEC
3 · Initial statement of ownershipAug 2, 2023Insider tradeSEC
3 · Initial statement of ownershipAug 2, 2023Insider tradeSEC
3 · Initial statement of ownershipAug 2, 2023Insider tradeSEC
3 · Initial statement of ownershipAug 2, 2023Insider tradeSEC
CERT · Exchange's certificate of listingJul 31, 2023Other filingsSEC
CORRESP · Letter to the SECJul 31, 2023Other filingsSEC
CORRESP · Letter to the SECJul 31, 2023Other filingsSEC
8-A12B · Registration of shares for listing on an exchangeJul 31, 2023Other filingsSEC
S-1/A · Registration statement, amendedJul 28, 2023Offer documentSEC
S-1/A · Registration statement, amendedJul 25, 2023Offer documentSEC
S-1/A · Registration statement, amendedJul 21, 2023Offer documentSEC
S-1/A · Registration statement, amendedJul 18, 2023Offer documentSEC
CORRESP · Letter to the SECJul 14, 2023Other filingsSEC
S-1/A · Registration statement, amendedJul 14, 2023Offer documentSEC
CORRESP · Letter to the SECJul 13, 2023Other filingsSEC
UPLOAD · Letter from the SECJul 10, 2023Other filingsSEC
CORRESP · Letter to the SECJun 29, 2023Other filingsSEC
S-1 · Registration statementJun 29, 2023Offer documentSEC
UPLOAD · Letter from the SECJun 15, 2023Other filingsSEC
DRSLTR · Letter to the SEC with a draftJun 8, 2023Other filingsSEC
DRS/A · Draft registration statement, amendedJun 8, 2023Offer documentSEC
UPLOAD · Letter from the SECMay 30, 2023Other filingsSEC
DRS/A · Draft registration statement, amendedMay 2, 2023Offer documentSEC
DAug 1, 2022Other filingsSEC
DAug 1, 2022Other filingsSEC
DRS · Draft registration statementJun 29, 2022Offer documentSEC

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from MIRA Pharmaceuticals, Inc.’s releases · as of Nov 13, 2026

Common shares
42,022,087
Fully diluted
42,022,087

Fully diluted

LineSharesAs of
Common shares42,022,087Nov 13, 2026

Share count over time

CountShares
Nov 13, 202642,022,087

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard970K2.3%US$820KSep 30, 2026
Geode Capital409K0.97%US$346KSep 30, 2026
Cross Staff Investments Inc359K0.86%US$304KSep 30, 2026
Citadel224K0.53%US$189KSep 30, 2026
BlackRock215K0.51%US$182KSep 30, 2026
Captrust Financial Advisors90,6450.22%US$76,577Sep 30, 2026
State Street76,9000.18%US$64,965Sep 30, 2026
Northern Trust67,7350.16%US$57,223Sep 30, 2026
Commonwealth Equity Services, LLC65,2030.16%US$55,080Sep 30, 2026
First American Bank60,0000.14%US$50,688Sep 30, 2026
All 23 holders
HolderSharesOf the companyValueAs of
International Assets Investment Management, LLC35,0000.08%US$25,305Sep 30, 2026
Fifth Third Bancorp20,0000.05%US$16,896Sep 30, 2026
Mariner, LLC16,5000.04%US$13,939Sep 30, 2026
Cary Street Partners Financial LLC10,0000.02%US$8,448Sep 30, 2026
Federation des caisses Desjardins du Quebec8,0000.02%US$6,760Sep 30, 2026
Nuveen2,180<0.01%US$1,900Sep 30, 2026
Osaic Holdings, Inc.2,000<0.01%US$1,680Sep 30, 2026
RBC1,227<0.01%US$1,000Sep 30, 2026
UBS624<0.01%US$527Sep 30, 2026
Capital Analysts, LLC165<0.01%US$139Sep 30, 2026
Robinhood Markets, Inc.90<0.01%US$76Sep 30, 2026
Tower Research Capital LLC (TRC)79<0.01%US$67Sep 30, 2026
Caitong International Asset Management Co., Ltd1<0.01%US$1Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund394K0.94%US$373KJun 30, 2026
Vanguard Extended Market Index Fund356K0.85%US$336KJun 30, 2026
Fidelity Extended Market Index Fund140K0.33%US$148KMay 31, 2026
iShares Micro-Cap ETF127K0.30%US$120KJun 30, 2026
Fidelity Series Total Market Index Fund42,0490.10%US$44,572May 31, 2026
Fidelity Total Market Index Fund35,8950.09%US$38,049May 31, 2026
Fidelity Nasdaq Composite Index Fund19,7050.05%US$20,887May 31, 2026
1290 VT Micro Cap Portfolio8,2370.02%US$7,796Jun 30, 2026
Vanguard Balanced Index Fund2,214<0.01%US$2,096Jun 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Christopher C Chapman Jr
Other companies: Telomir Pharmaceuticals, Inc. (CEO & Chairman, Director · Feb 8, 2024 – Feb 8, 2024 · Past); Q/C Technologies, Inc. (President, Chief Med. Officer, Director · Apr 16, 2021 – Jun 7, 2023 · Past); Rock Creek Pharmaceuticals Inc (President, Director · Sep 22, 2006 – Dec 27, 2013 · Past)
Executive Chairman, Director · Aug 2, 2023 – Aug 17, 2023 · Past
Michael Jerman
Other companies: Alaunos Therapeutics, Inc. (Managing Partner of Hollywell Partners · Since at least Jul 15, 2025); Inhibitor Therapeutics Inc. (Director · Since at least Apr 1, 2024); Telomir Pharmaceuticals, Inc. (Director · Feb 8, 2024 – Aug 27, 2024 · Past)
Director · Nov 14, 2023 – Mar 25, 2024 · Past
Alan Weichselbaum
Other companies: FinWise Bancorp (Director · Since at least May 27, 2025); Telomir Pharmaceuticals, Inc. (Chief Financial Officer · May 15, 2025 – May 15, 2025 · Past)
Chief Financial Officer · May 15, 2025 – May 15, 2025 · Past
Hugh McColl III
Other companies: Westrock Coffee Company (Director · Since at least Aug 26, 2022); Telomir Pharmaceuticals, Inc. (Director · Feb 8, 2024 – Feb 8, 2024 · Past)
Director · Aug 2, 2023 – Aug 2, 2023 · Past
Michelle Yanez
Other companies: Inhibitor Therapeutics Inc. (Director · Since at least Dec 13, 2022); Telomir Pharmaceuticals, Inc. (Chief Financial Officer · Jun 18, 2024 – Aug 27, 2024 · Past)
Chief Financial Officer · Aug 2, 2023 – Dec 9, 2024 · Past
Andriy Mushak
Other companies: Telomir Pharmaceuticals, Inc. (Chief Financial Officer · Since at least Jun 3, 2026)
Chief Financial Officer · Since at least Jun 2, 2026
Bradley Kroenig
Other companies: Telomir Pharmaceuticals, Inc. (Director · Feb 8, 2024 – Feb 8, 2024 · Past)
Director · Aug 2, 2023 – Aug 2, 2023 · Past
Brian Frederick Daly
Other companies: RRE Ventures Acquisition Corp. (Director · Since at least Mar 25, 2026)
Director · Oct 25, 2023 – Oct 25, 2023 · Past
David C Vorhoff
Other companies: Sonic Automotive, Inc. (Director · Apr 19, 2012 – Apr 18, 2013 · Past)
Director · Aug 2, 2023 – Aug 2, 2023 · Past
Edward Clouston MacPherson
Other companies: Telomir Pharmaceuticals, Inc. (Director · Since at least Aug 8, 2024)
Director · Since at least Mar 13, 2024
All 17 people
PersonSeat
Erez Aminov
Other companies: Telomir Pharmaceuticals, Inc. (Chairman and Chief Executive Officer · Since at least May 28, 2025)
Chief Executive Officer, Director · Since at least Aug 29, 2025
Matthew Del Giudice
Other companies: Telomir Pharmaceuticals, Inc. (Director · Since at least Nov 4, 2026)
Director · Since at least Nov 4, 2026
Matthew Pratt Whalen
Other companies: Telomir Pharmaceuticals, Inc. (Director · Since at least Aug 8, 2024)
Director · Since at least Nov 18, 2024
Ned MacPherson
Other companies: Telomir Pharmaceuticals, Inc. (Director · Since at least Nov 4, 2026)
Director · Since at least Nov 4, 2026
Talhia Tuck
Other companies: Telomir Pharmaceuticals, Inc. (Director · Feb 8, 2024 – Feb 8, 2024 · Past)
Director · Aug 2, 2023 – Aug 2, 2023 · Past
Denil N. ShekhatDirector · Since at least Oct 1, 2025
Itzchak AngelChief Scientific Advisor · Since at least Oct 29, 2026

Open People

Log in to ask 6ix AI your own questions about MIRA Pharmaceuticals, Inc.